早期乳腺癌术前自动乳腺超声乳腺组织构成与癌多灶性评估准确性及无复发生存的相关性
回顾性分析409例早期乳腺癌患者,术前自动乳腺超声(ABUS)联合数字乳腺X线摄影(DM)评估癌多灶性的准确率为90.0%,背景回声类型和腺体组织成分不影响该准确率。中位随访3.5年发生11例复发,ABUS不均匀背景回声、高腺体组织成分、BRCA突变及病理肿瘤较大与较差的无复发生存独立相关。
要点
- ABUS联合DM评估早期乳腺癌癌多灶性分类准确率达90.0%。
- ABUS背景回声类型和腺体组织成分不影响ABUS+DM的癌多灶性评估准确性。
- ABUS不均匀背景回声与较差无复发生存独立相关(HR 11.24)。
核心结论
- 早期乳腺癌患者术前ABUS不均匀背景回声和高腺体组织成分、较大肿瘤尺寸及BRCA突变与较差无复发生存相关,但背景回声和腺体组织成分不影响ABUS联合DM的癌多灶性评估。
研究设计与样本
- 回顾性分析纳入2019年10月至2021年4月间接受ABUS和数字乳腺X线摄影的临床Tis、T1-2/N0期早期乳腺癌女性409例(平均年龄50.2±8.7岁)。
关键影像表现/征象
- ABUS背景回声类型分为均匀脂肪型、均匀纤维腺体型和不均匀型。
- 在乳腺X线摄影致密乳腺亚组中,ABUS腺体组织成分进一步分为高(中度或显著)和低(轻微或轻度)。
- ABUS联合DM对癌多灶性分类(单灶、多灶/多中心或双侧)准确分类368例(90.0%)。
诊断标准与关键数值
- ABUS+DM癌多灶性分类准确率90.0%(368/409)。
- 全组中,不均匀背景回声与RFS独立相关(HR 11.24,95%CI 2.82-44.92,P=0.001)。
- 全组中,BRCA突变与RFS独立相关(HR 15.94,95%CI 2.47-102.97,P=0.004)。
- 全组中,病理索引癌每增加1 cm与RFS独立相关(HR 1.91,95%CI 1.13-3.23,P=0.02)。
- 致密乳腺亚组中,不均匀背景回声(HR 14.17,95%CI 2.69-74.60,P=0.002)和高腺体组织成分(HR 10.32,95%CI 2.35-45.28,P=0.002)与RFS独立相关。
临床应用与阅片要点
- ABUS联合DM可用于早期乳腺癌术前癌多灶性评估,背景回声和腺体组织成分不影响其准确性。
- 术前ABUS显示不均匀背景回声或高腺体组织成分时,提示与较差无复发生存相关。
- BRCA突变和病理肿瘤较大也与较差无复发生存独立相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate whether breast tissue composition on preoperative automated breast ultrasound (ABUS) is associated with the accuracy of cancer multiplicity evaluation and postoperative recurrence-free survival (RFS) in patients with early-stage breast cancer.
MATERIALS AND METHODS: This retrospective analysis included women with early-stage breast cancer (clinical Tis, T1-2/N0) who underwent ABUS and digital mammography (DM) between October 2019 and April 2021. Tissue composition on ABUS was assessed using the Breast Imaging Reporting and Data System background echotexture (BE) (homogeneous-fat, homogeneous-fibroglandular, or heterogeneous). In a subgroup of patients with mammographically dense breasts, the glandular tissue component (GTC) on ABUS were further stratified into high (moderate or marked) or low (minimal or mild). Multivariable logistic and Cox regression analyses were used to identify factors associated with accurate cancer multiplicity categorization (unifocal, multifocal/multicentric, or bilateral) using ABUS + DM, and with RFS, respectively.
RESULTS: Among 409 women (mean age ± standard deviation, 50.2 ± 8.7 years), ABUS combined with DM yielded accurate cancer multiplicity categorization in 368 patients (90.0%). Neither BE nor GTC on ABUS affected the accuracy of categorization when ABUS was combined with DM. Over a median postoperative follow-up of 3.5 years, 11 recurrences occurred. Heterogeneous BE on ABUS (hazard ratio [HR] 11.24 [95% confidence interval [CI]: 2.82-44.92]; P = 0.001), BRCA mutation (HR 15.94 [2.47-102.97]; P = 0.004), and pathologic index cancer size (HR per 1-cm increase 1.91 [1.13-3.23]; P = 0.02) was independently associated with RFS. In patients with dense breasts, heterogeneous BE (HR 14.17 [95% CI: 2.69-74.60]; P = 0.002) and high GTC (HR 10.32 [2.35-45.28]; P = 0.002) on ABUS, BRCA mutation (HR 24.34 [2.75-215.06]; P = 0.004), and pathologic cancer size (HR per 1-cm increase 2.62 [1.50-4.59]; P = 0.001) was independently associated with RFS.
CONCLUSION: In patients with early-stage breast cancer, heterogeneous BE and high GTC on preoperative ABUS, along with larger cancer size and BRCA mutation, was associated with worse RFS. However, BE and GTC did not affect cancer multiplicity evaluation when ABUS was used in combination with DM.
引用
- Kim MK, Kim H, Baek SY, et al. Association of Breast Tissue Composition on Preoperative Automated Breast Ultrasound With Accuracy of Cancer Multiplicity Evaluation and Recurrence-Free Survival in Patients With Early-Stage Breast Cancer. Korean J Radiol. 2026. PMID: 41592548. doi:10.3348/kjr.2025.1249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。